Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

NCT04511702 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Uncontrolled Gout
Gout
Uncontrolled Gout

Interventions

BIOLOGICAL: Pegloticase with MTX

Sponsor

Amgen